Xeris Biopharma Holdings, Inc. Common Stock XERS
$8.73
+6.52%
at last close
Financials (TTM)
- Revenue
- $33.38 million
- Net Income
- $-83,783,000
- Net Margin
- -251.01%
- Return on Equity
- -421.27%
- Debt-to-Equity
- 4.40
- P/E Ratio
- —
- Price / Book
- 75.17
- Price / Sales
- 44.79
Over the trailing twelve months, Xeris Biopharma Holdings, Inc. Common Stock generated revenue of $33.38 million and net income of $-83,783,000, a net margin of -251.01%.
At the last closing price of $8.73, XERS trades at 44.79 times sales, with a market capitalization of $1.50 billion.
Key Stats
- Last Close
- $8.73
- Market Cap
- $1.50 billion
- 52-Week Range
- $5.25 – $10.08
- Average Volume
- 1.72 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.